Table 2

Process metrics

Process metricsUsual care (n=122)CRT-CPW (n=115)P value*
Mean±SDMedian (IQR)Mean±SDMedian (IQR)
Outpatient clinic visits (n)10.8±4.110.0 (8–13)10.1±4.310.0 (7–12)0.21
 Pre procedure1.2±1.51.0 (0–2)1.6±1.41.0 (0–2)0.010
 Post procedure6.8±2.77.0 (5–8)7.5±3.57.0 (5–10)0.099
Outpatient clinic consultations (n)8.1±3.38.0 (6–10)9.9±4.210.0 (7–12)<0.001
 Pre procedure1.2±1.51.0 (0–2)2.1±1.82.0 (0–3)<0.0001
 Post procedure6.9±2.87.0 (5–8)7.8±3.77.0 (5–10)0.059
 Physician2.6±2.12.0 (1–4)1.7±1.42.0 (1–2)<0.001
 HF nurse1.7±2.01.0 (0–3)2.4±1.52.0 (1–3)<0.0001
 Pacemaker/ICD nurse0.0±0.30.0 (0–0)0.8±0.71.0 (0–1)<0.0001
 Pacemaker/ICD technician3.7±1.53.0 (3–4)4.3±2.54.0 (3–5)0.063
 Time to treatment37.0±26.329.2 (16–53)23.6±18.421.0 (10–31)0.002
 Length of hospital stay (days)4.8±9.32.0 (1–2)2.4±4.81.0 (1–2)<0.0001
 Post procedure (implant to discharge)1.5±0.72.0 (1–2)1.1±1.21.0 (0–1)<0.0001
 Same-day discharge (%)7%28%<0.0001
 ≤1 night stay (%)43%78%<0.0001
 Follow-up (discharge to 1 year)3.2±9.20.0 (0–0)1.3±4.60.0 (0–0)0.27
  • *P-value compares old and new pathways. Tests used are Wilcoxon ranksumand Fisher exact tests. P-value<0.05 is considered significant

  • CRT, cardiac resynchronisation therapy; CRT-CPW, CRT care pathway; HF, heart failure; ICD, implantable cardioverter-defibrillator.